Preliminary results of a phase II trial of pembrolizumab following autologous stem cell transplant in treatment of Hodgkin lymphoma. (Abstract only)
Home / Resource Library / PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation